T&R Biofab Co. Ltd (246710) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of T&R Biofab Co. Ltd stock KRW 1,502, price KRW 1,720, that is 12.7% below the price, quality 20 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
T&R Biofab Co. Ltd
246710 · KQExpensive (fair value 13% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 1,194 KRW – 29,229 KRW · fair‑value band 1,127 KRW – 1,878 KRW · the 1,720 KRW price screens above the 1,502 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether T&R Biofab Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals.
Show moreShow less
The company was founded in 2013 and is based in Siheung-si, South Korea.
Stock analysis
T&R Biofab Co. Ltd (246710) currently trades at 1,720 KRW, while our estimate is 1,502 KRW, 13% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 1,127 KRW (bear) to 1,878 KRW (bull), the price of 1,720 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 20/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
T&R Biofab Co. Ltd reported revenue of 27.0B KRW in FY2025 versus 3.2B KRW in FY2021, a compound +69.9%/yr. Reported net income was −34.9B KRW in FY2025.
Key figures
Market cap 81.9B KRW (≈ $61.3M) Micro · P/S ratio 2.65 · EPS (TTM) −582.61 KRW · Net margin −84.7% · Return on equity −128% · Return on assets (EBIT) −11.0% (5-year average) · Operating margin −12.1% · Revenue (TTM) 32.7B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 7 out of 100 (low confidence).
What moves the price
The share trades about 62% below its 52-week high and 38% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −16% fair-value upside, at −13%, 246710 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
246710 screens overvalued: fair value 13% below the price. Compare with Abbott Laboratories, →
Compare T&R Biofab Co. Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- PEG screener for stocks with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs 246710 |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs 246710 |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs 246710 |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥185.38 | ¥197.34 | +6% | vs 246710 |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs 246710 |
| Siemens Healthineers AG SHL | €43.30 | €34.51 | −20% | vs 246710 |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs 246710 |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs 246710 |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs 246710 |
| Koninklijke Philips N.V PHIA | €27.16 | €15.23 | −44% | vs 246710 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is T&R Biofab Co. Ltd (246710) overvalued or undervalued?
What is the fair value of 246710?
What is the quality score of 246710?
What is the price target for T&R Biofab Co. Ltd (246710)?
What is the T&R Biofab Co. Ltd stock forecast for 2026?
What is the revenue of T&R Biofab Co. Ltd (246710)?
What is the intrinsic value of T&R Biofab Co. Ltd (246710)?
Is T&R Biofab Co. Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 246710?
How much is T&R Biofab Co. Ltd worth?
What do the bullish and bearish scenarios say about 246710?
How solid is the balance sheet of T&R Biofab Co. Ltd (246710)?
How far is 246710 from its 52-week high?
Which stocks are comparable to T&R Biofab Co. Ltd?
Is T&R Biofab Co. Ltd stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of T&R Biofab Co. Ltd (246710)?
What should I pay attention to with T&R Biofab Co. Ltd right now?
Key figures of T&R Biofab Co. Ltd
How large is the market capitalisation of T&R Biofab Co. Ltd (246710)?
What is the P/S ratio of T&R Biofab Co. Ltd (246710)?
What are the earnings per share of T&R Biofab Co. Ltd (246710)?
What is the net margin of T&R Biofab Co. Ltd (246710)?
What is the return on equity of T&R Biofab Co. Ltd (246710)?
What is the EBIT return on assets of T&R Biofab Co. Ltd (246710)?
What is the operating margin of T&R Biofab Co. Ltd (246710)?
How fast is revenue growing at T&R Biofab Co. Ltd (246710)?
How much free cash flow does T&R Biofab Co. Ltd (246710) generate?
How much net debt does T&R Biofab Co. Ltd (246710) carry?
Watch T&R Biofab Co. Ltd in the live analysis
One click puts T&R Biofab Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.